title: Fetal radiation exposure induces testicular cancer in genetically susceptible mice.
abstract: The prevalence of testicular germ cell tumors (TGCT), a common solid tissue malignancy in young men, has been annually increasing at an alarming rate of 3%. Since the majority of testicular cancers are derived from germ cells at the stage of transformation of primordial germ cell (PGC) into gonocytes, the increase has been attributed to maternal/fetal exposures to environmental factors. We examined the effects of an estrogen (diethylstilbestrol, DES), an antiandrogen (flutamide), or radiation on the incidence of testicular germ cell tumors in genetically predisposed 129.MOLF-L1 (L1) congenic mice by exposing them to these agents on days 10.5 and 11.5 of pregnancy. Neither flutamide nor DES produced noticeable increases in testis cancer incidence at 4 weeks of age. In contrast, two doses of 0.8-Gy radiation increased the incidence of TGCT from 45% to 100% in the offspring. The percentage of mice with bilateral tumors, weights of testes with TGCT, and the percentage of tumors that were clearly teratomas were higher in the irradiated mice than in controls, indicating that irradiation induced more aggressive tumors and/or more foci of initiation sites in each testis. This radiation dose did not disrupt spermatogenesis, which was qualitatively normal in tumor-free testes although they were reduced in size. This is the first proof of induction of testicular cancer by an environmental agent and suggests that the male fetus of women exposed to radiation at about 5-6 weeks of pregnancy might have an increased risk of developing testicular cancer. Furthermore, it provides a novel tool for studying the molecular and cellular events of testicular cancer pathogenesis.
authors.affiliation: Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. sgunapal@mdanderson.org
authors.forename: Gunapala
authors.initials: G
authors.lastname: Shetty
authors.forename: Paul B
authors.initials: PB
authors.lastname: Comish
authors.forename: Connie C Y
authors.initials: CC
authors.lastname: Weng
authors.forename: Angabin
authors.initials: A
authors.lastname: Matin
authors.forename: Marvin L
authors.initials: ML
authors.lastname: Meistrich
mesh_terms: D000726:Androgen Antagonists / Q000633:toxicity; D000818:Animals; D004054:Diethylstilbestrol / Q000633:toxicity; D004968:Estrogens, Non-Steroidal / Q000633:toxicity; D005260:Female; D005333:Fetus / Q000528:radiation effects*; D005485:Flutamide / Q000633:toxicity; D020022:Genetic Predisposition to Disease; D008297:Male; D018811:Maternal Exposure; D051379:Mice; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000235:genetics; D013736:Testicular Neoplasms / Q000209:etiology*
chemical_list: D000726:Androgen Antagonists; D004968:Estrogens, Non-Steroidal; D004054:Diethylstilbestrol; D005485:Flutamide